{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"IgA Nephropathy: Pathogenesis, Progression, Precision Care \ud83e\uddec","description":"IgA nephropathy remains the most common immune-mediated glomerular disease worldwide \u2014 and up to 50% of patients may progress to kidney failure within a decade. \ud83e\uddec &amp;nbsp; The 2025 KDIGO guidance emphasizes early biopsy (proteinuria \u22650.5 g\/day), tight BP control (&amp;lt;120\/70), renin-angiotensin system inhibition, SGLT2 inhibitors, and targeted therapies such as budesonide and complement inhibition. &amp;nbsp; Proteinuria remains the key modifiable driver. Precision nephrology is here \u2014 and measurable. \ud83e\ude7a\ud83d\udcc9 ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40082245\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/198482480"}